Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Valeritas Holdings Inc. VLRXQ

Valeritas Holdings Inc is a commercial-stage medical technology company. It is engaged in the business of improving health and simplifying life for diabetic patients by developing and commercializing innovative technologies. The company designed its first commercialized product, the V-Go Wearable Insulin Delivery Device, or V-Go, that supports the patients with Type 2 diabetes who need insulin to achieve and maintain their target blood glucose goals. V-Go is a small easy-to-use disposable insuli


OTCPK:VLRXQ - Post by User

Comment by dmacdon Jan 14, 2019 1:55pm
83 Views
Post# 29228956

RE:symbol VLRX Valeritas Holdings

RE:symbol VLRX Valeritas HoldingsI also averaged down towards year end. Nice to see the device being preferred to insurers. Sales will pick up for sure. Royalties from other countries are deferred but will pick up early next year and foreign partner sales results will hopefully be announced each trailing quarter. Should be a great stock ... fingers crossed that profitability will be apparent within 2 qtrs .. if so the SP will rocket. A risk with it being so tightly held by institutions is manipulation but lets hope for no more shady deals on the financing side. The retail side may not be worth chasing down.
<< Previous
Bullboard Posts
Next >>